Role of the mucins in pathogenesis of COPD: implications for therapy.

Expert Review of Respiratory Medicine
Federica Lo BelloGaetano Caramori

Abstract

Introduction: Evidence accumulated in the last decade has started to reveal the enormous complexity in the expression, interactions and functions of the large number of different mucins present in the different compartments of the human lower airways. This occurs both in normal subjects and in COPD patients in different clinical phases and stages of severity.Areas covered: We review the known physiological mechanisms that regulate mucin production in human lower airways of normal subjects, the changes in mucin synthesis/secretion in COPD patients and the clinical efficacy of drugs that modulate mucin synthesis/secretion.Expert opinion: It is evident that the old simplistic concept that mucus hypersecretion in COPD patients is associated with negative clinical outcomes is not valid and that the therapeutic potential of 'mucolytic drugs' is under-appreciated due to the complexity of the associated molecular network(s). Likewise, our current knowledge of the effects of the drugs already available on the market that target mucin synthesis/secretion/structure in the lower airways is extremely limited and often indirect and more well-controlled clinical trials are needed in this area.

References

Jan 1, 1990·The American Review of Respiratory Disease·Y MajimaY Sakakura
Jul 1, 1988·Drug Intelligence & Clinical Pharmacy·D T Brown
Jan 1, 1987·Respiration; International Review of Thoracic Diseases·B G Disse, H W Ziegler
Oct 1, 1986·The Biochemical Journal·J K SheehanI Carlstedt
Jun 20, 1968·The New England Journal of Medicine·J C HoggW M Thurlbeck
Mar 1, 1980·The American Review of Respiratory Disease·R MartinC Marriott
Dec 26, 1995·Biochemical and Biophysical Research Communications·E G GollubZ Marom
Dec 1, 1996·Drugs·K L Dechant, S Noble
Apr 1, 1997·American Journal of Respiratory and Critical Care Medicine·P W Jones, T K Bosh
Apr 20, 1999·Chest·D A MahlerW H Anderson
Jul 26, 2000·Molecular Biology and Evolution·J L DesseynA Laine
Jan 3, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·E P LillehojK C Kim
May 2, 2002·Anti-cancer Drugs·S Zweegman, P C Huijgens
Aug 13, 2002·The Laryngoscope·Hajime IshinagaYuichi Majima
Oct 24, 2002·The Journal of Biological Chemistry·Hong Wang, David L Brautigan
Dec 5, 2002·The Journal of Allergy and Clinical Immunology·Matthias Salathe
Jun 28, 2003·American Journal of Respiratory and Critical Care Medicine·Takeshi ShimizuYuichi Majima
May 8, 2004·American Journal of Respiratory and Critical Care Medicine·Koichi HashimotoR Stokes Peebles
Dec 24, 2005·Physiological Reviews·Mary Callaghan Rose, Judith A Voynow
Dec 27, 2005·Respiratory Physiology & Neurobiology·Daisuke InoueHidetada Sasaki
Mar 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wenju LuK Chul Kim
Jun 9, 2007·Biochemical and Biophysical Research Communications·Yuxian HuangJian-Dong Li
Jun 9, 2007·American Journal of Respiratory and Critical Care Medicine·James C HoggFrank C Sciurba
Sep 14, 2007·Annual Review of Physiology·David J ThorntonMichael A McGuckin
Oct 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tiange LangTore Samuelsson
Nov 9, 2007·Annual Review of Physiology·C William Davis, Burton F Dickey
Nov 27, 2007·Biochemical and Biophysical Research Communications·Huahao ShenJian-Dong Li
Dec 22, 2007·American Journal of Respiratory Cell and Molecular Biology·Seyed Javad MoghaddamBurton F Dickey
Dec 22, 2007·American Journal of Respiratory Cell and Molecular Biology·Long P NguyenRichard A Bond
Mar 15, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Daisuke InoueMutsuo Yamaya
Sep 9, 2008·American Journal of Respiratory and Critical Care Medicine·Sara KirkhamDavid J Thornton
Nov 4, 2008·American Journal of Respiratory Cell and Molecular Biology·Lingxiang ZhuYin Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pulmonary Pharmacology & Therapeutics
C W Davis, L H Abdullah
Annual Review of Physiology
Philip ThaiReen Wu
The Laryngoscope
Mahmoud S Ali, Jeffrey P Pearson
© 2021 Meta ULC. All rights reserved